Methods and compositions for retarding weight gain...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/554 (2006.01) A61K 31/4045 (2006.01) A61K 31/428 (2006.01) A61K 31/473 (2006.01) A61K 31/48 (2006.01) A61K 31/4985 (2006.01) A61K 31/519 (2006.01) A61K 31/5513 (2006.01) A61P 3/04 (2006.01) A61P 3/10 (2006.01)

Patent

CA 2622696

Methods and compositions for preventing or reducing weight gain and associated metabolic syndrome in patients receiving atypical antipsychotic drugs for treatment of mental illnesses are described. The invention comprises administering to a patient in need of treatment an effective amount of a dopamine agonist in conjunction with an effective amount of an atypical antipsychotic drug. In one embodiment of the invention, the dopamine agonist is pramipexole. The dopamine agonist may be administered in a low dose, such as less than 1 mg per day of pramipexole. Examples of atypical antipsychotic drugs which may be administered in conjunction with the dopamine agonist include clozapine, olanzapine, quetiapine and risperadone.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Methods and compositions for retarding weight gain... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and compositions for retarding weight gain..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for retarding weight gain... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1545096

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.